NCT00911859 · BASELINE
Baseline characteristics
Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.
- denoms
- counts
- group Id
- BG000
- value
- 12
- group Id
- BG001
- value
- 54
- group Id
- BG002
- value
- 52
- group Id
- BG003
- value
- 118
- units
- Participants
- groups
- description
- Siltuximab 11 mg/kg as a 1-hour intravenous infusion every 3 weeks along with VMP. VMP: Velcade 1.3 mg/m2 was administered as an intravenous bolus injection according to the current approved package inserts. Melphalan 9 mg/m2 and prednisone 60 mg/m2 were taken orally.
- id
- BG000
- title
- Part 1: VMP (Velcade+Melphalan+Prednisone) + Siltuximab
- description
- Velcade 1.3 mg/m2 was administered as an intravenous bolus injection according to the current approved package inserts. Melphalan 9 mg/m2 and prednisone 60 mg/m2 were taken orally.
- id
- BG001
- title
- Part 2: VMP (Velcade+Melphalan+Prednisone)
- description
- Siltuximab 11 mg/kg as a 1-hour intravenous infusion every 3 weeks along with VMP. VMP: Velcade 1.3 mg/m2 was administered as an intravenous bolus injection according to the current approved package inserts. Melphalan 9 mg/m2 and prednisone 60 mg/m2 were taken orally.
- id
- BG002
- title
- Part 2: VMP (Velcade+Melphalan+Prednisone) + Siltuximab
- description
- Total of all reporting groups
- id
- BG003
- title
- Total
- measures
- classes
- categories
- measurements
- group Id
- BG000
- spread
- 6.3
- value
- 73.6
- group Id
- BG001
- spread
- 7.27
- value
- 70.3
- group Id
- BG002
- spread
- 4.76
- value
- 71.6
- group Id
- BG003
- spread
- 6.21
- value
- 71.2
- dispersion Type
- STANDARD_DEVIATION
- param Type
- MEAN
- title
- Age, Continuous
- unit Of Measure
- years
- classes
- categories
- measurements
- group Id
- BG000
- value
- 7
- group Id
- BG001
- value
- 30
- group Id
- BG002
- value
- 29
- group Id
- BG003
- value
- 66
- title
- Female
- measurements
- group Id
- BG000
- value
- 5
- group Id
- BG001
- value
- 24
- group Id
- BG002
- value
- 23
- group Id
- BG003
- value
- 52
- title
- Male
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Sex: Female, Male
- unit Of Measure
- Participants
- classes
- categories
- measurements
- group Id
- BG000
- value
- 0
- group Id
- BG001
- value
- 2
- group Id
- BG002
- value
- 2
- group Id
- BG003
- value
- 4
- title
- AUSTRALIA
- categories
- measurements
- group Id
- BG000
- value
- 0
- group Id
- BG001
- value
- 5
- group Id
- BG002
- value
- 2
- group Id
- BG003
- value
- 7
- title
- FRANCE
- categories
- measurements
- group Id
- BG000
- value
- 0
- group Id
- BG001
- value
- 3
- group Id
- BG002
- value
- 1
- group Id
- BG003
- value
- 4
- title
- INDIA
- categories
- measurements
- group Id
- BG000
- value
- 0
- group Id
- BG001
- value
- 7
- group Id
- BG002
- value
- 5
- group Id
- BG003
- value
- 12
- title
- ISRAEL
- categories
- measurements
- group Id
- BG000
- value
- 0
- group Id
- BG001
- value
- 2
- group Id
- BG002
- value
- 2
- group Id
- BG003
- value
- 4
- title
- ITALY
- categories
- measurements
- group Id
- BG000
- value
- 0
- group Id
- BG001
- value
- 5
- group Id
- BG002
- value
- 11
- group Id
- BG003
- value
- 16
- title
- POLAND
- categories
- measurements
- group Id
- BG000
- value
- 0
- group Id
- BG001
- value
- 2
- group Id
- BG002
- value
- 0
- group Id
- BG003
- value
- 2
- title
- ROMANIA
- categories
- measurements
- group Id
- BG000
- value
- 0
- group Id
- BG001
- value
- 10
- group Id
- BG002
- value
- 10
- group Id
- BG003
- value
- 20
- title
- RUSSIAN FEDERATION
- categories
- measurements
- group Id
- BG000
- value
- 0
- group Id
- BG001
- value
- 3
- group Id
- BG002
- value
- 2
- group Id
- BG003
- value
- 5
- title
- SINGAPORE
- categories
- measurements
- group Id
- BG000
- value
- 0
- group Id
- BG001
- value
- 7
- group Id
- BG002
- value
- 8
- group Id
- BG003
- value
- 15
- title
- SOUTH KOREA
- categories
- measurements
- group Id
- BG000
- value
- 12
- group Id
- BG001
- value
- 5
- group Id
- BG002
- value
- 7
- group Id
- BG003
- value
- 24
- title
- SPAIN
- categories
- measurements
- group Id
- BG000
- value
- 0
- group Id
- BG001
- value
- 3
- group Id
- BG002
- value
- 2
- group Id
- BG003
- value
- 5
- title
- UNITED STATES
- param Type
- NUMBER
- title
- Region of Enrollment
- unit Of Measure
- participants
Complete source fields
- denoms
- counts
- group Id
- BG000
- value
- 12
- group Id
- BG001
- value
- 54
- group Id
- BG002
- value
- 52
- group Id
- BG003
- value
- 118
- units
- Participants
- groups
- description
- Siltuximab 11 mg/kg as a 1-hour intravenous infusion every 3 weeks along with VMP. VMP: Velcade 1.3 mg/m2 was administered as an intravenous bolus injection according to the current approved package inserts. Melphalan 9 mg/m2 and prednisone 60 mg/m2 were taken orally.
- id
- BG000
- title
- Part 1: VMP (Velcade+Melphalan+Prednisone) + Siltuximab
- description
- Velcade 1.3 mg/m2 was administered as an intravenous bolus injection according to the current approved package inserts. Melphalan 9 mg/m2 and prednisone 60 mg/m2 were taken orally.
- id
- BG001
- title
- Part 2: VMP (Velcade+Melphalan+Prednisone)
- description
- Siltuximab 11 mg/kg as a 1-hour intravenous infusion every 3 weeks along with VMP. VMP: Velcade 1.3 mg/m2 was administered as an intravenous bolus injection according to the current approved package inserts. Melphalan 9 mg/m2 and prednisone 60 mg/m2 were taken orally.
- id
- BG002
- title
- Part 2: VMP (Velcade+Melphalan+Prednisone) + Siltuximab
- description
- Total of all reporting groups
- id
- BG003
- title
- Total
- measures
- classes
- categories
- measurements
- group Id
- BG000
- spread
- 6.3
- value
- 73.6
- group Id
- BG001
- spread
- 7.27
- value
- 70.3
- group Id
- BG002
- spread
- 4.76
- value
- 71.6
- group Id
- BG003
- spread
- 6.21
- value
- 71.2
- dispersion Type
- STANDARD_DEVIATION
- param Type
- MEAN
- title
- Age, Continuous
- unit Of Measure
- years
- classes
- categories
- measurements
- group Id
- BG000
- value
- 7
- group Id
- BG001
- value
- 30
- group Id
- BG002
- value
- 29
- group Id
- BG003
- value
- 66
- title
- Female
- measurements
- group Id
- BG000
- value
- 5
- group Id
- BG001
- value
- 24
- group Id
- BG002
- value
- 23
- group Id
- BG003
- value
- 52
- title
- Male
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Sex: Female, Male
- unit Of Measure
- Participants
- classes
- categories
- measurements
- group Id
- BG000
- value
- 0
- group Id
- BG001
- value
- 2
- group Id
- BG002
- value
- 2
- group Id
- BG003
- value
- 4
- title
- AUSTRALIA
- categories
- measurements
- group Id
- BG000
- value
- 0
- group Id
- BG001
- value
- 5
- group Id
- BG002
- value
- 2
- group Id
- BG003
- value
- 7
- title
- FRANCE
- categories
- measurements
- group Id
- BG000
- value
- 0
- group Id
- BG001
- value
- 3
- group Id
- BG002
- value
- 1
- group Id
- BG003
- value
- 4
- title
- INDIA
- categories
- measurements
- group Id
- BG000
- value
- 0
- group Id
- BG001
- value
- 7
- group Id
- BG002
- value
- 5
- group Id
- BG003
- value
- 12
- title
- ISRAEL
- categories
- measurements
- group Id
- BG000
- value
- 0
- group Id
- BG001
- value
- 2
- group Id
- BG002
- value
- 2
- group Id
- BG003
- value
- 4
- title
- ITALY
- categories
- measurements
- group Id
- BG000
- value
- 0
- group Id
- BG001
- value
- 5
- group Id
- BG002
- value
- 11
- group Id
- BG003
- value
- 16
- title
- POLAND
- categories
- measurements
- group Id
- BG000
- value
- 0
- group Id
- BG001
- value
- 2
- group Id
- BG002
- value
- 0
- group Id
- BG003
- value
- 2
- title
- ROMANIA
- categories
- measurements
- group Id
- BG000
- value
- 0
- group Id
- BG001
- value
- 10
- group Id
- BG002
- value
- 10
- group Id
- BG003
- value
- 20
- title
- RUSSIAN FEDERATION
- categories
- measurements
- group Id
- BG000
- value
- 0
- group Id
- BG001
- value
- 3
- group Id
- BG002
- value
- 2
- group Id
- BG003
- value
- 5
- title
- SINGAPORE
- categories
- measurements
- group Id
- BG000
- value
- 0
- group Id
- BG001
- value
- 7
- group Id
- BG002
- value
- 8
- group Id
- BG003
- value
- 15
- title
- SOUTH KOREA
- categories
- measurements
- group Id
- BG000
- value
- 12
- group Id
- BG001
- value
- 5
- group Id
- BG002
- value
- 7
- group Id
- BG003
- value
- 24
- title
- SPAIN
- categories
- measurements
- group Id
- BG000
- value
- 0
- group Id
- BG001
- value
- 3
- group Id
- BG002
- value
- 2
- group Id
- BG003
- value
- 5
- title
- UNITED STATES
- param Type
- NUMBER
- title
- Region of Enrollment
- unit Of Measure
- participants
Download exact source JSON → · Snapshot ctgov-results-25a395029948b04d52b1253f
Preserved source evidence · Not medical advice
Triangle